Blue Copper 5 PRIME Eye — Clinical Results

Clinical Results

Blue Copper 5 PRIME Eye

Every active in PRIME Eye is clinically dosed — checked against its own clinical study before it earns a place. Here is the evidence.

What users saw in 4 weeks

Before
Before using Blue Copper 5 PRIME Eye
After 4 weeks
After 4 weeks of Blue Copper 5 PRIME Eye

Photography of an individual user following twice-daily use for 4 weeks. Individual results vary.

94%

saw a lifted, firmer eye area

94%

saw reduced crow’s feet

96%

said dark circles looked reduced

100%

said their eyes looked more awake

Consumer perception study over 4 weeks of twice-daily use.

The ingredient evidence

Matrikine peptide complex

Clinically dosed — an exact match to the studied level

The matrikine peptide duo that signals the skin to rebuild collagen. PRIME Eye carries it at the same concentration used in the clinical study below.

Clinical result vs placebo (2 months) Figure
Surface area occupied by deep wrinkles (>200µm) -44.9%
Main wrinkle density -37.0%
Average wrinkle depth -15.1%
Skin tone +19.5%

Method: Two panels of 23 volunteers aged 39–74; half-face, placebo-controlled, twice daily for 2 months; confocal analysis of silicone skin imprints. Supplier clinical study of the ingredient; not conducted on the finished Osmotics product.

The confirmed peptide stack

Every active checked against the batch formula

Unlike most eye creams, every active in PRIME Eye is present at its supplier-recommended working concentration — verified against our manufacturing formula, not estimated from an ingredient list. The concentrations themselves are proprietary; what we publish is that each one clears the bar.

Active Clinically dosed
Matrikine peptide complex — collagen signalling ✓
Eye peptide complex — puffiness and dark circles ✓
Darutoside — smoothing ✓
Upper-eyelid lifting active ✓
Firming peptide (acetyl tetrapeptide-2) ✓
Prezatide copper acetate — the Blue Copper peptide ✓

Doses confirmed against the quantitative manufacturing formula and the suppliers’ published use levels; the formula itself is proprietary. Remaining supplier clinical dossiers are being obtained and their results will be published here.

Blue Copper (prezatide copper acetate)

Pioneered by Osmotics in 1998

Copper peptides (GHK-Cu) are among the most-studied molecules in skin science, with peer-reviewed research since 1988 showing they stimulate collagen synthesis in fibroblasts and support the skin’s natural repair processes.

References: Maquart et al., FEBS Letters, 1988; Pickart & Margolina, Cosmetics, 2017.

Shop PRIME Eye